ICER Colloquium Series: July 24-August 7, 2020
Pricing in a Pandemic: Options, Debate, a Path Forward
Session One: Cost-Recovery Pricing
- Webinar Date:July 24, 2020, from 12-1:30 pm ET
- Speakers:
- Afton Cissell, JD, Senior Counsel to Congressman Lloyd Doggett (D-Tex)
- Ronny Gal, Analyst, Sanford C. Bernstein
- David Mitchell, Founder, Patients For Affordable Drugs
- Aaron Kesselheim, MD, JD, MPH, Professor of Medicine, Brigham and Women’s Hospital/Harvard Medical School
- Randy Burkholder, Vice President, Policy and Research at PhRMA
- Audience: Free and open to the public. Click here for the webinar slides
- WATCH WEBINAR RECORDING
Session Two: Cost-Effectiveness and Value-Based Pricing
- Webinar Date:July 31, 2020, from 12-1:30 pm ET
- Speakers:
- Jon Campbell, PhD, Associate Professor, Pharmaceutical Outcomes Research, University of Colorado
- Bobby Dubois, MD, PhD, Chief Science Officer and Executive Vice President, National Pharmaceutical Council
- Craig Garthwaite, PhD, Associate Professor of Strategy, Kellogg School of Management, Northwestern University
- Steve Miller, MD, Chief Clinical Officer, Cigna
- Eleanor Perfetto, PhD, Executive Vice President of Strategic Initiatives, National Health Council
- Audience: Free and open to the public. Click here for the webinar slides
- WATCH WEBINAR RECORDING
Session Three: Monetary Prizes, Compulsory Licensing, Advanced Market Commitments
- Webinar Date: August 7, 2020, from 12-1:30 pm ET
- Speakers:
- Peter Bach, MD, Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
- James Love, MPA, Director, Knowledge Ecology International
- Nicole Lurie, MD, MSPH, Strategic Advisor to the CEO, Coalition for Epidemic Preparedness Innovations, and Former Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services during the Obama Administration
- Carl Schmid, MBA, Executive Director, HIV + Hepatitis Policy Institute
- Adrian Towse, MA, Emeritus Director & Senior Research Fellow, OHE, and Visiting Professor, London School of Economics
- Audience: Free and open to the public. Click here for the webinar slides
- WATCH WEBINAR RECORDING
The webinar series included discussion on the following ICER reports:
- Our white paper on, “Alternative Policies for Pricing Novel Vaccines and Drug Therapies for COVID-19”
- Our ICER-COVID models